1-[[4-[2-(5-CHLORO-2-METHOXYBENZAMIDO)-ETHYL]-PHENYL]-SULFONYL]-3-(TRANS-2-HYDROXYCYCLOHEXYL)-UREA
Compound with spectra: 1 NMR
![1-[[4-[2-(5-CHLORO-2-METHOXYBENZAMIDO)-ETHYL]-PHENYL]-SULFONYL]-3-(TRANS-2-HYDROXYCYCLOHEXYL)-UREA](/api/compound/4mQMF8ZJ7xP.png?ph=true&h=300&w=458 "1-[[4-[2-(5-CHLORO-2-METHOXYBENZAMIDO)-ETHYL]-PHENYL]-SULFONYL]-3-(TRANS-2-HYDROXYCYCLOHEXYL)-UREA")
| SpectraBase Compound ID | 4mQMF8ZJ7xP |
|---|---|
| InChI | InChI=1S/C23H28ClN3O6S/c1-33-21-11-8-16(24)14-18(21)22(29)25-13-12-15-6-9-17(10-7-15)34(31,32)27-23(30)26-19-4-2-3-5-20(19)28/h6-11,14,19-20,28H,2-5,12-13H2,1H3,(H,25,29)(H2,26,27,30)/t19-,20-/m1/s1 |
| InChIKey | PASKIAZVROHUGZ-WOJBJXKFSA-N |
| Mol Weight | 510.01 g/mol |
| Molecular Formula | C23H28ClN3O6S |
| Exact Mass | 509.138735 g/mol |
| Enantiomer InChIKey | PASKIAZVROHUGZ-PMACEKPBSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
1-{2-[2,5-BIS(2,2,2-TRIFLUOROETHOXY)BENZAMIDO]ETHYL}-3-(p-TOLYL-SULFONYL)UREA
5-chloro-N-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]-2-methoxybenzamide
5-chloro-2-methoxy-N-[2-(1-piperidinyl)phenyl]benzamide
5-chloro-N-(2-fluoro-5-nitrophenyl)-2-methoxybenzamide
ethanaminium, 2-[[2-chloro-4-[(5-chloro-2-methoxybenzoyl)amino]benzoyl]oxy]-N,N-diethyl-, chloride
2-(Diethylamino)ethyl 2-chloro-4-[(5-chloro-2-methoxybenzoyl)amino]benzoate
5-chloro-2-methoxy-N-[1-(2-methylbenzyl)-1H-pyrazol-4-yl]benzamide
methyl 3-[(5-chloro-2-methoxybenzoyl)amino]-2-thiophenecarboxylate
Mosapride
4-AMINO-5-CHLORO-2-ETHOXY-N-[[(4-BENZYL)-2-MORPHINYL]-METHYL]-BENZAMIDE;IMPURITY
| Title | Journal or Book | Year |
|---|---|---|
| Hydroxyl-Substituted sulfonylureas as potent inhibitors of specific [3H]Glyburide binding to rat brain synaptosomes | Bioorganic & Medicinal Chemistry | 2003 |